Program Overview
Integrated Nutritional Support for Patients on GLP-1 Therapy for Weight Management
Structured, clinically supervised nutrition and lifestyle care designed to improve tolerance, reduce side effects, and optimise outcomes alongside GLP-1 therapy.
Why structured nutritional support matters with GLP-1 therapy
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for weight management and metabolic disorders. While clinically effective, they are associated with:
- Significant appetite suppression
- Gastrointestinal (GI) side effects such as constipation, diarrhoea, nausea, and bloating
- Inadequate dietary adaptation, leading to suboptimal outcomes and poor adherence
Despite pharmacological efficacy, structured nutritional guidance is often lacking, resulting in avoidable side effects and compromised patient experience.

Program Objective
Clinically supervised nutritional and lifestyle care, ensuring:
- Improved treatment tolerance
- Reduced GI adverse events
- Optimised metabolic and weight loss outcomes
- Enhanced patient compliance and satisfaction
Core Pillars
Three pillars guiding every patient journey
Program Methodology
A structured, three-step clinical pathway
Baseline Clinical Assessment
Detailed evaluation of:
- Current dietary intake
- Lifestyle factors (sleep, activity, stress)
- Existing metabolic or chronic conditions
- Identification of risk factors for GI intolerance and nutritional gaps
Personalized 10-Day Adaptation Protocol
Customized plan based on:
- GLP-1 dosage and titration phase
- Individual metabolic profile
Focus areas:
- Portion recalibration
- Meal timing and composition
- Hydration and fiber optimization
Goal: Facilitate physiological adaptation and minimize adverse effects.
Continuous Monitoring & Follow-ups
Regular, structured follow-ups to:
- Track GI symptoms and tolerance
- Adjust dietary protocols dynamically
- Reinforce adherence and patient education


Expected Outcomes
What patients and clinicians can expect
- Reduction in early-stage GI side effects
- Improved patient adherence to GLP-1 therapy
- Better nutritional adequacy despite reduced appetite
- Enhanced weight loss and metabolic outcomes
- Increased patient confidence and satisfaction
A comprehensive care ecosystem around GLP-1 therapy
- Supports holistic patient management alongside pharmacotherapy
- Improves real-world treatment outcomes and persistence rates
- Reduces drop-offs due to side effects
- Positions therapy within a comprehensive care ecosystem
Bring structured nutritional care to your GLP-1 patients
Connect with our clinical team to learn how the program integrates with your treatment plan.
Book a Consultation